Skip Navigation

JNCI Monographs 2008 2008(39):83-86; doi:10.1093/jncimonographs/lgn007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Ross, J. A.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ross, J. A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press.

Environmental and Genetic Susceptibility to MLL-Defined Infant Leukemia

Julie A. Ross

Affiliation of author: Division of Pediatric Epidemiology & Clinical Research, Department of Pediatrics, University of Minnesota Cancer Center, Minneapolis, MN

Correspondence to: Julie A. Ross, PhD, Division of Pediatric Epidemiology & Clinical Research, Department of Pediatrics, University of Minnesota Cancer Center, MMC 422, 420 Delaware St. S.E., Minneapolis, MN 55455 (e-mail: ross{at}umn.edu).

The study of rare cancers, including retinoblastoma, angiosarcoma, and vaginal clear cell carcinoma, has contributed greatly to our understanding of cancer mechanisms. Infants with leukemia may represent another important rare group. The majority of infants with leukemia have MLL gene rearrangements in their leukemia cells, and there is unequivocal laboratory evidence that these arise in utero. There is increasing evidence that environmental and genetic factors may contribute to the risk of MLL-defined infant leukemias. Because the infant exposure experience is only a small window in comparison to that of an individual who develops a malignancy in middle or late age, the pivotal factors responsible for this genetic anomaly may be easier to identify. With the largest case–control study of infant leukemia ever conducted underway in the Children's Oncology Group (COG AE24), there is a unique opportunity to integrate epidemiological data with laboratory data on MLL status and genotype.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J Natl Cancer Inst MonogrHome page
C. S. Rabkin and S. Janz
Overview of Mechanisms and Consequences of Chromosomal Translocation
J Natl Cancer Inst Monographs, July 1, 2008; 2008(39): 1 - 1.
[Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.